Time to entry for new cancer medicines: from European Union wide marketing authorisation to patient access in Belgium, Estonia, Scotland, and Sweden

10 July 2018 - This study quantified the median time from European Union wide approval to first use for a ...

Read more →

Vertex reaches agreement in Sweden for reimbursement of Orkambi

18 June 2018 - Vertex Pharmaceuticals announced that Orkambi (lumacaftor/ivacaftor), the first medicine to treat the underlying cause of cystic ...

Read more →

Patients call for end to two-year row over cystic fibrosis drug funding

19 June 2018 - UK patients are stepping up efforts to resolve the “heartbreaking” row that is denying their families ...

Read more →

Sweden launches campaign to host EU drugs agency instead of UK after Brexit

8 December 2016 - Britain's negotiations over leaving the EU have not even begun and already European countries are vying ...

Read more →